Dr. Naveen Chandra G SHOD and Lead Consultant - Department of Interventional Cardiology, Aster Whitefield Hospital, Bengaluru ...

The protocols offer a more accurate way to detect atherosclerosis and assess cardiovascular risk before symptoms appear, ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

One of the most common signs that arteries might be blocked is chest pain, often called angina. People often describe it as a ...

"The emergence of DT-109 as a dual-action drug capable of treating both MASH and the vascular complications associated with atherosclerosis marks a significant advancement in the treatment ...